Petra Molan, PharmD MSc in

Petra Molan, PharmD MSc

Login to view DISC.
Chief Commercial Officer (CCO) at Mundipharma
📍 Zug, Zug, Switzerland

Petra Molan is a transformational C-suite executive in the pharma and biotech industries, currently serving as Chief Commercial Officer at Mundipharma. Known for being an authentic, inspiring, and people-focused leader, she has a proven track record of scaling businesses, including leading a biotech startup to a $1B valuation. She holds degrees from the University of Ljubljana and completed a leadership program at Harvard Business School.

Outside of her executive roles, Petra is passionate about fostering diverse and inclusive teams, viewing it as a competitive advantage and a key to innovation. She is a dedicated mentor and actively speaks on the importance of DE&I in the workplace, incorporating these principles into her leadership style to drive better business results and create a supportive environment.

Unique fact: Petra was the first female General Manager at a division of Bayer after 150 years of the companys history.

Read the full overview →
Experience
27 Years
Current Role
Chief Commercial Officer (CCO)
Job Level
Leadership
Location
Zug, Zug, Switzerland
Personality Overview

How Petra shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Petra cares about

Biotech Commercialization
Has extensive experience building biotech operations from scratch, launching products globally, and scaling a startup to a $1B valuation at sale.
Transformational Leadership
Her profile and recommendations consistently highlight her ability to reorganize and elevate businesses as a "transformational leader" who inspires her teams.
+5 more topics Login to view topics
Career

Work history

1-2024
Chief Commercial Officer (CCO)
Mundipharma
1-2023 - 12-2024
Board Member
Speratum Biopharma, Inc.
1-2023 - 12-2023
CEO & Partner
PMConsultingGroup GmbH
7-2021 - 12-2022
GM Region EMEAC (EU, ME, Canada) / Board Director CH - aquired by Amgen
Horizon
11-2019 - 6-2021
CCO / COO - Arvelle aquired by Angelini Pharma
Arvelle Therapeutics
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2013 - 2014
Global Leadership Development Program 2014
Harvard Business School Executive Education
11-2022 - 11-2023
International Board of Directors Certification
Swiss Board School
PharmD
University of Ljubljana, Faculty of Pharmacy
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Petra. Free, 10 seconds.